RTSM Resources
-
RTSM Automating Adaptive Enrollment In Basket Trials
6/26/2026
Adaptive basket trials need real-time data to close underperforming cohorts fast. See how automation closes that gap and protects patients.
-
IRT? RTSM? What's The Difference?
10/4/2024
What are the components of Randomization and Trial Supply Management (RTSM) and the critical role of RTSM and Interactive Response Technology (IRT) in clinical trials?
-
What Is Interactive Response Technology (IRT)?
6/25/2026
Learn how protocol-driven IRT systems support supply management and randomization to help trial teams cut risk and costs.
-
5 Ways To Get Ready For IRT Regulatory Inspections
7/31/2025
Preparing for a regulatory inspection during a clinical trial can be daunting. Learn about the importance of clear roles, audit trails, data integrity, and training, and get recommendations to help.
-
Paying Sites To Reduce Burden
6/12/2026
Beth Harper and Rosie Filling discuss site burden, enrollment pressure, and why sponsors should help pay for technology and training.
-
How Heron Therapeutics Sped Up Database Creation
12/2/2022
Electronic data capture (EDC) is straightforward, in theory. However, not every EDC is purpose-designed for ease of use by study teams, and some are easier to use and more intuitive than others.
-
Validation And Why Sponsors Say Yes
6/12/2026
Joe Dustin explains why validation documentation and sponsor benefit are key to getting approval for site-system integration.
-
Top 5 Dos And Don'ts Of RTSM
7/16/2024
Discover best practices and common pitfalls for sponsors and vendors in RTSM as well as how to optimize your study by leveraging vendor expertise, avoiding delays, and embracing innovation.
-
Why Site Burden Goes Beyond eSource
6/12/2026
Beth Harper explains why the real problem is broader than eSource and why sponsors should integrate around the systems sites already use.
-
Agentic RTSM That Takes A Study From Kickoff To UAT
8/5/2026
Discover how automated micropayments eliminate site paperwork, give participants instant access to funds, and provide real-time trial insights.